glivec 400 mg

Gleevec is a targeted therapy cancer treatment for specific types of leukemia, bone marrow disorders, skin cancers and certain tumors. It is an oral tablet that is taken once or twice a day. The dosage of Gleevec depends on the type of cancer and the phase of treatment. The 400-mg tablet is for chronic myeloid leukemia (Ph+ CML) in chronic phase. Glivec diindikasikan sebagai pengobatan untuk pasien kanker. Dosis Cara Penggunaan. Glivec termasuk dalam golongan obat keras. Harus dengan Resep Dokter. Protuberans Dermatofibrosarcoma. Dewasa: 400 mg 2 kali sehari. Leukemia Mieloid Kronis. Dewasa: Fase kronis: 400 mg setiap hari, dosis ditingkatkan menjadi 600 mg setiap hari atau 400 mg 2 ... Dose increases from 400 mg to 600 mg or 800 mg in patients with chronic phase disease, or from 600 mg to a maximum of 800 mg (given as 400 mg twice daily) in patients with accelerated phase or blast crisis may be considered in the absence of severe adverse drug reaction and severe non-leukaemia-related neutropenia or thrombocytopenia in the ... GLIVEC 400 MG TABLET is an anticancer medicine that treats and prevents the growth of certain types of cancers of your blood cells, stomach, intestine, bone marrow, and skin. It works by stopping the growth of cancer cells and preventing them from spreading. It has side effects like skin rash, weight gain, diarrhoea, headache, loss of appetite, vomiting, stomach pain, and hair loss. It should be taken with a meal to avoid stomach irritation and avoid grapefruit juice. Digunakan sebagai pengobatan untuk pasien kanker. Kandungan / Komposisi. Tiap tablet mengandung Imatinib mesilate 400 mg. Dosis. ATURAN PAKAI HARUS SESUAI DENGAN PETUNJUK DOKTER. 400 mg/hari untuk CML fase kronis, 600 mg/hari untuk pengobatan fase accelerated atau krisis blast. Cara Pemakaian. What it does The Food and Drug Administration (FDA) has approved Gleevec to treat certain types of blood cancers, including: Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in... Glivec 400mg Tablet is an anti-cancer medication. A protein enzyme, bcr-abl tyrosine kinase, responsible for the growth of abnormal proliferation of cancer cells. This medicine inhibits the proliferation and induces apoptosis (planned cell death) in bcr-abl positive cells (cancer cells). This is how it works to stop or slow the spread of cancer. Glivec is a medicine that contains the active substance imatinib. It is available as capsules (50 and 100 mg) and tablets (100 and 400 mg). harga glivec 400 mg box 10 tablet. rp844.928. harga glivec 400 mg box 10 tablet. rp9.431.507. harga glivec 100 mg box 60 tablet. rp5.069.566. harga glivec 100 mg blister 10 tablet. rp308.661. harga glivec 400 mg box 10 tablet. rp1.013.851. harga glivec 100 mg blister 10 tablet. rp316.847. harga glivec 400 mg box 10 tablet. rp7.129.078. harga ... The recommended dosage of Glivec is 400 mg/day for adult patients in chronic phase CML and 600 mg/day for patients in accelerated phase or blast crisis. The prescribed dose should be administered orally, once daily with a meal and a large glass of water. Dose increase from 400 mg to 600 mg in patients with chronic phase disease, or from 600 mg Dose increase from 100 mg to 400 mg may be considered in the absence of adverse drug reactions if assessments demonstrate an insufficient response to therapy. Treatment should be continued as long as the patient continues to benefit. Posology for GIST The recommended dose of Glivec is 400 mg/day for adult patients with unresectable and/or ... Glivec 400mg Tablets 30 - Imatinib. Drug Name: imatinib Product ID: 2521343. SELECT A PRESCRIPTION. IMPORTANT NOTE: A VALID AUSTRALIAN PRESCRIPTION IS REQUIRED TO BE SENT BY POST BEFORE THIS ITEM CAN BE SHIPPED LEARN MORE. PRIVATE PRESCRIPTION PRICE. Learn more. Learn more. 9.99. Temporarily Low Stock Online. 2. Obnovte léčbu Glivecem na úroveň předchozí dávky (tj. před vážnými nežádoucími reakcemi). Chronická fáze CML, MDS/MPD a GIST (zahajovací dávka 400 mg) HES/CEL (dávka 400 mg) ANC 1,0 x 109/l a/nebo. krevní destičky 50 x 109/l. 1. Přerušte podávání Glivecu, dokud není ANC 1,5 x 109/l a krevní destičky.